Annual CFI
-$29.56 M
-$21.48 M-265.90%
December 31, 2023
Summary
- As of February 8, 2025, KNSA annual cash flow from investing activities is -$29.56 million, with the most recent change of -$21.48 million (-265.90%) on December 31, 2023.
- During the last 3 years, KNSA annual CFI has fallen by -$6.11 million (-26.07%).
- KNSA annual CFI is now -122.98% below its all-time high of $128.63 million, reached on December 31, 2021.
Performance
KNSA Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$6.35 M
+$40.45 M+86.44%
September 30, 2024
Summary
- As of February 8, 2025, KNSA quarterly cash flow from investing activities is -$6.35 million, with the most recent change of +$40.45 million (+86.44%) on September 30, 2024.
- Over the past year, KNSA quarterly CFI has increased by +$5.93 million (+48.29%).
- KNSA quarterly CFI is now -107.15% below its all-time high of $88.79 million, reached on March 31, 2020.
Performance
KNSA Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$42.52 M
+$5.93 M+12.24%
September 30, 2024
Summary
- As of February 8, 2025, KNSA TTM cash flow from investing activities is -$42.52 million, with the most recent change of +$5.93 million (+12.24%) on September 30, 2024.
- Over the past year, KNSA TTM CFI has increased by +$14.81 million (+25.83%).
- KNSA TTM CFI is now -117.19% below its all-time high of $247.32 million, reached on September 30, 2021.
Performance
KNSA TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
KNSA Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -265.9% | +48.3% | +25.8% |
| 3 y3 years | -26.1% | -113.3% | -117.2% |
| 5 y5 years | +87.6% | -141.7% | -186.4% |
KNSA Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -123.0% | at low | -116.6% | +87.3% | -133.1% | +25.8% |
| 5 y | 5-year | -123.0% | at low | -107.2% | +95.8% | -117.2% | +52.9% |
| alltime | all time | -123.0% | +87.6% | -107.2% | +96.7% | -117.2% | +84.2% |
Kiniksa Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$6.35 M(-86.4%) | -$42.52 M(-12.2%) |
| Jun 2024 | - | -$46.80 M(-283.3%) | -$48.44 M(-243.0%) |
| Mar 2024 | - | $25.52 M(-271.4%) | $33.89 M(-214.6%) |
| Dec 2023 | -$29.56 M(+265.9%) | -$14.89 M(+21.3%) | -$29.56 M(-48.4%) |
| Sep 2023 | - | -$12.28 M(-134.6%) | -$57.32 M(+120.4%) |
| Jun 2023 | - | $35.53 M(-193.7%) | -$26.01 M(+11.7%) |
| Mar 2023 | - | -$37.92 M(-11.1%) | -$23.27 M(+188.1%) |
| Dec 2022 | -$8.08 M(-106.3%) | -$42.66 M(-324.1%) | -$8.08 M(-47.7%) |
| Sep 2022 | - | $19.04 M(-50.2%) | -$15.46 M(-215.8%) |
| Jun 2022 | - | $38.27 M(-268.4%) | $13.35 M(-78.1%) |
| Mar 2022 | - | -$22.72 M(-54.6%) | $61.08 M(-52.5%) |
| Dec 2021 | $128.63 M(-648.7%) | -$50.04 M(-204.6%) | $128.63 M(-48.0%) |
| Sep 2021 | - | $47.85 M(-44.4%) | $247.32 M(+396.5%) |
| Jun 2021 | - | $85.99 M(+91.8%) | $49.81 M(-173.9%) |
| Mar 2021 | - | $44.83 M(-34.7%) | -$67.40 M(+187.5%) |
| Dec 2020 | -$23.44 M | $68.64 M(-145.9%) | -$23.44 M(-74.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | -$149.66 M(+379.4%) | -$90.17 M(-220.7%) |
| Jun 2020 | - | -$31.22 M(-135.2%) | $74.70 M(-49.3%) |
| Mar 2020 | - | $88.79 M(+4534.1%) | $147.28 M(+199.3%) |
| Dec 2019 | $49.21 M(-120.6%) | $1.92 M(-87.4%) | $49.21 M(-36.1%) |
| Sep 2019 | - | $15.21 M(-63.2%) | $76.96 M(-157.8%) |
| Jun 2019 | - | $41.36 M(-545.8%) | -$133.13 M(-46.4%) |
| Mar 2019 | - | -$9.28 M(-131.3%) | -$248.40 M(+3.8%) |
| Dec 2018 | -$239.20 M(>+9900.0%) | $29.66 M(-115.2%) | -$239.20 M(-11.0%) |
| Sep 2018 | - | -$194.87 M(+163.7%) | -$268.86 M(+263.2%) |
| Jun 2018 | - | -$73.91 M(>+9900.0%) | -$74.02 M(>+9900.0%) |
| Mar 2018 | - | -$75.00 K(+1775.0%) | -$126.00 K(+82.6%) |
| Dec 2017 | -$69.00 K(+2200.0%) | -$4000.00(-85.7%) | -$69.00 K(+6.2%) |
| Sep 2017 | - | -$28.00 K(+47.4%) | -$65.00 K(+75.7%) |
| Jun 2017 | - | -$19.00 K(+5.6%) | -$37.00 K(+105.6%) |
| Mar 2017 | - | -$18.00 K | -$18.00 K |
| Dec 2016 | -$3000.00 | - | - |
FAQ
- What is Kiniksa Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals annual CFI year-on-year change?
- What is Kiniksa Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals quarterly CFI year-on-year change?
- What is Kiniksa Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals TTM CFI year-on-year change?
What is Kiniksa Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of KNSA is -$29.56 M
What is the all time high annual CFI for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high annual cash flow from investing activities is $128.63 M
What is Kiniksa Pharmaceuticals annual CFI year-on-year change?
Over the past year, KNSA annual cash flow from investing activities has changed by -$21.48 M (-265.90%)
What is Kiniksa Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of KNSA is -$6.35 M
What is the all time high quarterly CFI for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high quarterly cash flow from investing activities is $88.79 M
What is Kiniksa Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, KNSA quarterly cash flow from investing activities has changed by +$5.93 M (+48.29%)
What is Kiniksa Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of KNSA is -$42.52 M
What is the all time high TTM CFI for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high TTM cash flow from investing activities is $247.32 M
What is Kiniksa Pharmaceuticals TTM CFI year-on-year change?
Over the past year, KNSA TTM cash flow from investing activities has changed by +$14.81 M (+25.83%)